Back
MYT Netherlands Parent BV Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
57
MYTE
MYT Netherlands Parent BV
Last Price:
5.04
Seasonality Move:
4.46%
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
242.97
Seasonality Move:
20.36%
Buy
57
MYT Netherlands Parent BV (MYTE)
is a Buy
Is MYT Netherlands Parent BV a Buy, Sell or Hold?
- The current MYT Netherlands Parent BV [MYTE] share price is $5.10. The Score for MYTE is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- MYTE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $243.08. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MYTE Stock Price Chart
What is MYT Netherlands Parent BV's stock price today?
-
The MYT Netherlands Parent BV share price today is $5.10
The current trend is relatively stagnant and MYTE is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $243.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
MYTE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 51.06 | Buy |
Chaikin Money Flow: | 47824 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.9 - 5.64) | Sell |
Bollinger Bands (100): | (3.23 - 5.01) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 22.91 | Buy |
Relative Strength Index (14 RSI): | 86.77 | Buy |
Chaikin Money Flow: | -1210062 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.8 - 205.74) | Buy |
Bollinger Bands (100): | (136.44 - 176.64) | Buy |
MYTE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.95 | Buy |
20-day SMA: | 5.26 | Sell |
50-day SMA: | 4.85 | Buy |
200-day SMA: | 3.64 | Buy |
8-day EMA: | 5.01 | Buy |
20-day EMA: | 5.09 | Buy |
50-day EMA: | 4.82 | Buy |
200-day EMA: | 4.32 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 209.44 | Buy |
20-day SMA: | 176.25 | Buy |
50-day SMA: | 159.62 | Buy |
200-day SMA: | 165.96 | Buy |
8-day EMA: | 218.01 | Buy |
20-day EMA: | 188.75 | Buy |
50-day EMA: | 168.9 | Buy |
200-day EMA: | 168.09 | Buy |
MYT Netherlands Parent BV Earnings Growth & MYTE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.08 per share, and an increase next year of $0.20 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
MYT Netherlands Parent BV Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |